Immediate Impact
56 standout
Citing Papers
Pancreatic cancer
2025 Standout
Biomaterials mediated 3R (remove-remodel-repair) strategy: holistic management of Helicobacter pylori infection
2025 Standout
Works of Mok Oh being referenced
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
2023 Standout
The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta‐analysis
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Mok Oh | 236 | 254 | 124 | 24 | 545 | |
| Zizhen Zhang | 182 | 193 | 100 | 35 | 582 | |
| Andriy Rusyn | 277 | 202 | 102 | 16 | 463 | |
| Sang Ho Kim | 229 | 104 | 101 | 32 | 649 | |
| Yusuke Okuda | 178 | 84 | 117 | 32 | 514 | |
| William H. Falor | 104 | 112 | 320 | 34 | 579 | |
| Xianbao Zhan | 402 | 157 | 147 | 25 | 644 | |
| Saori Mishima | 448 | 336 | 133 | 36 | 647 | |
| Keren Jia | 280 | 174 | 78 | 19 | 472 | |
| Abderrahman Ouban | 139 | 97 | 77 | 33 | 535 | |
| S-E. Al-Batran | 213 | 288 | 173 | 21 | 464 |
All Works
Login with ORCID to disown or claim papers
Loading papers...